-
Ribociclib and Acid-Reducing Agents: A QbD Study
2026-09-02
This study combines Analytical Quality by Design with a biorelevant micro-dissolution model to examine whether gastric pH changes caused by acid-reducing agents alter ribociclib succinate performance. Although ribociclib solubility declined after experimentally imposed pH shifts, the integrated results indicated no clinically meaningful effect on expected absorption under the tested conditions.
-
Magneto-Piezoelectric Scaffolds for Infected Bone Repair
2026-09-02
The reference study develops a dual-responsive, 3D-printed scaffold that combines biofilm disruption with targeted metabolic activation of Icam1+ macrophages. Its central finding is that sequential magnetic-field and ultrasound stimulation can engage JAK2-STAT3-associated oxidative phosphorylation and improve regeneration in infectious bone defects.
-
Chlorpromazine Research Workflow for CNS Assays
2026-09-01
Build reproducible dopamine D2 receptor and antiemetic assays with chlorpromazine while preserving solvent, salt-form, and exposure controls. A cell-resolved nanoparticle framework adds a practical lesson: distinguish pharmacological response from nonspecific cellular uptake and tissue-distribution effects.
-
Danazol Models: From Steroid Biology to Translation
2026-09-01
Danazol is more than a historical endocrine drug: it is a mechanistically informative perturbagen for studying androgen receptor signaling, steroidogenesis, luteinizing hormone regulation, and hypothalamic–pituitary–gonadal axis biology. This thought-leadership article examines what the 2025 Danazol-induced rat model of precocious puberty reveals, how to build reproducible validation workflows, and where Danazol can—and cannot—support translational endocrinology and prostate cancer research.
-
PEI-Modified Laminarin Nanoparticles as Vaccine Adjuvants
2026-08-31
The reference study developed polyethyleneimine-modified Laminarin nanoparticles that combine cationic antigen loading with improved dendritic-cell uptake, maturation, lysosomal escape, and antigen cross-presentation. Using ovalbumin as a model antigen, the formulation produced stronger antibody and cellular immune responses than an aluminum-adjuvant comparator, supporting functionalized polysaccharides as rational nanovaccine adjuvants.
-
Adenosine Triphosphate (ATP) in Metabolic Research
2026-08-30
Adenosine Triphosphate (ATP) is a phosphoryl-transfer reagent, intracellular energy carrier, and extracellular signaling molecule. Its value in cellular metabolism research is strongest when ATP abundance, ATP-to-ADP balance, enzyme activity, and receptor context are measured separately.
-
H 89 2HCl for Reliable Cell Assays
2026-08-29
A scenario-based guide to using H 89 2HCl (SKU B2190) for interpreting viability, proliferation, phosphorylation, and cAMP/PKA signaling experiments. It covers solvent control, concentration selection, off-target interpretation, and practical supplier evaluation.
-
Erastin Ferroptosis Inducer: Workflow & Tips
2026-08-29
Use Erastin to model iron-dependent oxidative cell death in RAS- or BRAF-relevant tumor systems with orthogonal viability, ROS, and lipid-peroxidation readouts. This practical guide connects product handling with the GPR68–ferroptosis findings reported in lung and pancreatic cancer models while clearly separating validated evidence from proposed combination experiments.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-28
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines direct Cy5 cargo tracking with EGFP expression, separating delivery from productive translation in one experiment. Its Cap1 structure and 5-moUTP chemistry make it a practical reporter for macrophage-targeted nanoparticles, transfection optimization, and quantitative gene delivery studies.
-
DAMGO for Reliable µ-Opioid Assays
2026-08-28
Learn how DAMGO (SKU B6621) can support controlled µ-opioid receptor signaling research while reducing misinterpretation in viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects receptor selectivity, assay controls, handling, and vendor reliability to practical laboratory decisions.
-
Spermine Workflows for Ion Channel Research
2026-08-27
Spermine enables controlled studies of inward rectifier potassium channel modulation, cellular metabolism, and membrane-excitability effects. This workflow-focused guide also shows how to use it cautiously as a hypothesis-generating perturbation in herpesvirus nuclear egress research without overstating the evidence.
-
Erastin for Ferroptosis–Immunity Assays
2026-08-27
Erastin is a ferroptosis inducer that connects redox vulnerability with tumor immunology. This evidence-based guide presents a two-axis assay strategy for distinguishing direct ferroptotic death from immune effects in RAS/BRAF-relevant cancer biology research.
-
CCK-8, Endogenous Opioids, and Morphine Withdrawal
2026-08-26
Wen et al. show that centrally administered cholecystokinin octapeptide reduces anxiety-like behavior during morphine withdrawal through CCK1 receptor signaling and endogenous opioid involvement. The study distinguishes withdrawal-related negative affect from reward conditioning and identifies central CCK1 receptors as a mechanistically testable target for opioid addiction and withdrawal studies.
-
Chloroquine, COVID-19, and Antiviral Evidence
2026-08-26
Touret and de Lamballerie’s commentary uses cross-virus evidence to show why promising chloroquine activity in cell culture could not, by itself, justify clinical use against COVID-19. Its central contribution is a translational framework for separating in vitro signals from animal and human outcomes, with important implications for evaluating antiviral candidates in chronic viral disease research.
-
From CCK-8 Signal to Metabolic Mechanism in OSCC
2026-08-25
A mechanism-aware guide to using Cell Counting Kit-8 (CCK-8) in oral squamous cell carcinoma research, with practical advice for distinguishing metabolic effects from genuine changes in cell survival.